Reason for request
Inclusion
Clinical Benefit
| Substantial |
The actual benefit of NOVOEIGHT is substantial. |
Clinical Added Value
| no clinical added value |
NOVOEIGHT does not provide any improvement in actual benefit (level V, non-existent) in the treatment and prophylaxis of haemophilia A compared with other available treatments. |
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
fQVtH2GwmzgPAHhV
